title: [Voluven--third generation plasma expander].
abstract: Crystalloid solutions are considered a good choice for lower scale blood loss (up to 20%). The usage of colloids facilitates faster and more durable blood volume substitution. Besides, some colloids (HES 130/04) are considered to have a beneficial effect on microcirculation, capillary membrane integrity, inflammatory response and endothelium integrity. Colloid solutions characteristics as well as the possible side effects within their group vary. It is therefore important to know that HES 130/04, a new generation colloid solution, is linked to a lower frequency of side effects. Nonetheless, it seems that the individual approach and procedure-specific choices are more important than other factors.
authors: Klinika za anesteziologiju, reanimatologiju i intenzivnu medicinu, Klinicka bolnica Dubrava, Zagreb.
authors: Ino
authors: I
authors: Husedzinović
authors: Tin
authors: T
authors: Ehrenfreund
authors: Ada
authors: A
authors: Hauptman
mesh_terms: D003102:Colloids; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects / Q000627:therapeutic use*; D010952:Plasma Substitutes / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D003102:Colloids; C485123:HES 130-0.4; D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes